Trends
Long COVID Therapeutics and Care Models: Navigating Ethics, Policy, and Patient Realities
A single persistent cough can declare a battle that medical science is only beginning to understand. With millions still grappling...
Read more
STAT’s “AI Prognosis” Predicts Regulatory Crackdown: Media, Policy, and Social Debate Collide
A single forecast can unsettle an entire industry. In its July 2 edition, STAT’s “AI Prognosis” newsletter canvassed more than...
Read more
Microplastics Found in Semen and Follicular Fluid: Emerging Fertility Fears and Infection Risks
A minuscule fragment can reshape our understanding of human reproduction. On July 1, researchers presented data at the European Society...
Read more
Record Heat, Record ER Visits: Climate Extremes Strain Kidneys and Hearts
An unrelenting sun can transform familiar streets into furnaces. Over the past week, Europe endured its most severe heatwave in...
Read more
AI Medical Scribes Hit a Tipping Point Amid Adoption Boom and Legal Scrutiny
A solitary statistic can pivot an industry’s direction overnight. On July 2, a physician survey uncovered that 27 percent of...
Read more
Waiting for Relief: Payment Reform, Patient Psychology, and Emergency Care in the NHS
A glance at a crowded corridor can determine whether a sore throat eclipsed by anxiety prompts a patient to leave...
Read more
Shifting Frontiers: How Climate Change Redraws the Map of Tick-Borne Disease
A single tick bite on a New England hiking trail may soon resemble the risk once confined to lower latitudes...
Read more
Off-Label Uprising: GLP-1 Therapies, Consumer Demand, and the New Meaning of Prescription
A quiet upheaval has rippled through pharmacies and clinician offices as glucagon-like peptide-1 therapies once confined to diabetes management now...
Read more
Virtual Frontiers and Neural Links: Telehealth’s Expansion and the Muskian Dilemma
A distant hum of notifications heralds a new era of clinical encounters conducted via screens, sensors and simulated environments. Telemedicine...
Read more
Continuous Care, Continuous Data: How AI-Powered Remote Monitoring Redefines Diagnostics
A quiet revolution unfolds beyond clinic walls where wristbands and patches transmit a torrent of vital signs to distant clinicians....
Read more
Generative Scribes and Pervasive Errors: The Promise and Pitfalls of AI-Driven Clinical Notes
An unseen burden weighs beneath the hum of hospital workstations. Across thousands of encounters each day, clinicians wrestle with documentation...
Read more
When Algorithms Chase Profits: Big Tech’s AI Race and the Price of Patient Care
In the hushed corridors of modern hospitals, a new brand of rivalry is taking shape—one measured in teraflops and quarterly...
Read more
FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation
Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read morePopular
-
How the Use of Sedation in Dentistry Has Changed Over Time
-
Rural Hospital Merger Ends Emergency Department
-
Simple Daily Habits for Head-to-Toe Wellness and Lasting Health
-
When Health Records Become Hostage: The Rise of Espionage in Healthcare Data Breaches
-
The Flexner Report and the Rise of Pharmaceutical Hegemony
